Phorbol myristate acetate treatment of normal human myeloid blast cells promotes monopoiesis and inhibits granulopoiesis.

Abstract:

:Fractionation of mononuclear cells from human fetal liver provides a cell population at early stages of myeloid differentiation which, when cultured, generates neutrophils and macrophages for up to a month. These studies describe the further purification of an undifferentiated myeloid blast cell population by rosette sedimentation of unwanted cells, after coating these cells with monoclonal antibodies which identify macrophages and erythroblasts. In culture, the purified blast cells generated only neutrophils and macrophages. When treated with 10 nM PMA, 62% of the purified cells were induced to differentiate towards macrophages within 48 h. PMA-induced cells acquired morphological features of macrophages and synthesized alpha-naphthyl acetate esterase. The differentiation of the remaining blast cells towards neutrophils, seen in untreated cultures, was completely inhibited by PMA, as revealed by the absence of increases in the numbers of cells expressing lactoferrin and an antigen which appears at the promyelocyte stage of differentiation. Thus, PMA effects intracellular changes which both promote monopoiesis and inhibit granulopoiesis, suggesting a reciprocal interaction between intracellular processes which regulate the capacity for the two pathways of maturation. The purified blast cell population provides a good model system for studies of molecular events which regulate the expression of macrophage characteristics.

journal_name

Leuk Res

journal_title

Leukemia research

authors

Bunce CM,Patton WN,Pound JD,Lord JM,Brown G

doi

10.1016/0145-2126(90)90114-o

subject

Has Abstract

pub_date

1990-01-01 00:00:00

pages

1007-17

issue

11-12

eissn

0145-2126

issn

1873-5835

journal_volume

14

pub_type

杂志文章
  • Prognostic classification of patients with acute lymphoblastic leukemia by using gene copy number profiles identified from array-based comparative genomic hybridization data.

    abstract::The development of risk-adapted therapy has improved the treatment results of acute lymphoblastic leukemia (ALL) especially in children. However, more accurate risk classifiers are warranted. In this study we aimed at defining a prognostic classifier based on DNA copy number alterations of adolescent and young adult (...

    journal_title:Leukemia research

    pub_type: 杂志文章

    doi:10.1016/j.leukres.2010.02.031

    authors: Usvasalo A,Elonen E,Saarinen-Pihkala UM,Räty R,Harila-Saari A,Koistinen P,Savolainen ER,Knuutila S,Hollmén J

    更新日期:2010-11-01 00:00:00

  • Changes in thymidine kinase activity during differentiation of HL-60 leukemic cells.

    abstract::Induction of granulocyte maturation in HL-60 leukemic cells by DMSO (1.2%) or RA (1 microM) is accompanied by a 50-60% decrease in cellular thymidine kinase activity. Similarly, the differentiation of HL-60 cells into monocyte-macrophage phenotype by the addition of PMA is paralleled by a 60-80% suppression of thymidi...

    journal_title:Leukemia research

    pub_type: 杂志文章

    doi:10.1016/0145-2126(87)90079-8

    authors: Borelli TJ,Miyamoto S,Wertheimer SJ,Wu JM

    更新日期:1987-01-01 00:00:00

  • Glycosylation interference on RhoA activation: focus on G-CSF.

    abstract::Glycosylation of cytokines appears to be responsible for several differences in their activity, and focusing on G-CSF, several divergences between the non-glycosylated G-CSF, Filgrastim, and the glycosylated G-CSF, Lenograstim, have been reported. To verify the role of G-CSF glycosylation in mediating these difference...

    journal_title:Leukemia research

    pub_type: 杂志文章

    doi:10.1016/j.leukres.2010.05.027

    authors: Mattii L,Battolla B,Azzarà A,D'Urso G,Montali U,Petrini M

    更新日期:2011-02-01 00:00:00

  • Monoclonal gammopathies in B-cell non-Hodgkin's lymphomas.

    abstract::The association of monoclonal gammopathy (MG) with B-cell non-Hodgkin's lymphomas (NHL) is a well known phenomenon. The aim of the present work was to study the incidence, type of monoclonal component and prognostic significance of MG in a population of 255 cases with B-cell NHL. Among 255 evaluable patients with B-ce...

    journal_title:Leukemia research

    pub_type: 杂志文章

    doi:10.1016/s0145-2126(02)00277-1

    authors: Economopoulos T,Papageorgiou S,Pappa V,Papageorgiou E,Valsami S,Kalantzis D,Xiros N,Dervenoulas J,Raptis S

    更新日期:2003-06-01 00:00:00

  • The intracellular location of terminal transferase does not vary with cell cycle stage.

    abstract::The biochemical activity of terminal transferase (TdT) in the thymocytes of leukemic AKR mice has no relationship to cell cycle stage, unlike the activity of replicative DNA polymerase which increases during the period of DNA synthesis. Moreover, such assays of DNA polymerase alpha reveal a shift in enzyme activity fr...

    journal_title:Leukemia research

    pub_type: 杂志文章

    doi:10.1016/0145-2126(84)90082-1

    authors: Barr RD,Barresi T,Koekebakker M,Sarin PS

    更新日期:1984-01-01 00:00:00

  • Fatal hyperleukocytic syndrome in a patient with chronic myelomonocytic leukemia.

    abstract::A 53-year-old male patient was admitted to our hospital with painful splenomegaly. He was diagnosed as having chronic myelomonocytic leukemia (CMML) with leukocytosis, monocytosis, increased lysozyme concentrations in serum und urine, and lack of the Philadelphia chromosome. The clinical course of the disease was char...

    journal_title:Leukemia research

    pub_type: 杂志文章

    doi:10.1016/s0145-2126(96)00117-8

    authors: Aul C,Gattermann N,Germing U,Südhoff T,Hollmig KA,Heyll A

    更新日期:1997-03-01 00:00:00

  • Epigenetic regulation of signal transducer and activator of transcription 3 in acute myeloid leukemia.

    abstract::We have demonstrated that constitutive signal transducer and activator of transcription (STAT) 3 activity, observed in approximately 50% of acute myeloid leukemia (AML) cases, is associated with adverse treatment outcome. Constitutive STAT3 activation may result from the expression of oncogenic protein tyrosine kinase...

    journal_title:Leukemia research

    pub_type: 杂志文章,评审

    doi:10.1016/j.leukres.2007.11.035

    authors: Ghoshal Gupta S,Baumann H,Wetzler M

    更新日期:2008-07-01 00:00:00

  • Iron overload in myelodysplastic syndromes: Evidence based guidelines from the Canadian consortium on MDS.

    abstract::In 2008 the first evidence-based Canadian consensus guideline addressing the diagnosis, monitoring and management of transfusional iron overload in patients with myelodysplastic syndromes (MDS) was published. The Canadian Consortium on MDS, comprised of hematologists from across Canada with a clinical and academic int...

    journal_title:Leukemia research

    pub_type: 杂志文章,评审

    doi:10.1016/j.leukres.2018.09.005

    authors: Leitch HA,Buckstein R,Zhu N,Nevill TJ,Yee KWL,Leber B,Keating MM,St Hilaire E,Kumar R,Delage R,Geddes M,Storring JM,Shamy A,Elemary M,Wells RA

    更新日期:2018-11-01 00:00:00

  • 2CdA chemotherapy and rituximab in the treatment of marginal zone lymphoma.

    abstract::Standard chemotherapic approach for MZL is missing. We are presenting our monocenter experience with 2CdA+/-rituximab. Patients received 2CdA, 5mg/m(2), weekly, for 6 weeks. Patients receiving rituximab underwent to antibody administration in association with 2CdA, or after the end of chemotherapy. Global ORR was 89.3...

    journal_title:Leukemia research

    pub_type: 临床试验,杂志文章

    doi:10.1016/j.leukres.2009.04.003

    authors: Orciuolo E,Buda G,Sordi E,Baraté C,Galimberti S,Ciancia E,Petrini M

    更新日期:2010-02-01 00:00:00

  • Characterization of cell markers in type B retroviral-induced thymic lymphomas--I. Surface antigen phenotype and karyotype in developing and primary lymphomas.

    abstract::CFW/D mice injected neonatally with a type B retrovirus, (DMBA-LV), rapidly develop thymic lymphomas. The present study examined simultaneously the karyotype and the expression of surface antigens on thymocytes from DMBA-LV treated mice at 28, 35 and 42 days of age during the development of lymphomas, and of cells fro...

    journal_title:Leukemia research

    pub_type: 杂志文章

    doi:10.1016/0145-2126(89)90122-7

    authors: Mueller RE,Ball JK,Chan FP

    更新日期:1989-01-01 00:00:00

  • Bortezomib-induced peripheral neuropathy in multiple myeloma: a comparison between previously treated and untreated patients.

    abstract::Peripheral neuropathy (PN), with neuropathic pain as main symptom, represents the dose-limiting toxicity of the proteasome inhibitor bortezomib. Aim of this study was to compare the incidence, risk factors, severity and outcome of PN and neuropathic pain in patient treated with bortezomib up-front or at relapse. We st...

    journal_title:Leukemia research

    pub_type: 杂志文章

    doi:10.1016/j.leukres.2009.07.022

    authors: Corso A,Mangiacavalli S,Varettoni M,Pascutto C,Zappasodi P,Lazzarino M

    更新日期:2010-04-01 00:00:00

  • Adverse prognostic value of MYBL2 overexpression and association with microRNA-30 family in acute myeloid leukemia patients.

    abstract::The MYBL2 gene encodes a transcription factor implicated in cell proliferation and maturation whose amplification or overexpression has been associated with different human malignancies, suggesting that it could be implicated in tumorigenesis. We analyzed MYBL2 expression and its prognostic value in 291 patients with ...

    journal_title:Leukemia research

    pub_type: 杂志文章

    doi:10.1016/j.leukres.2013.09.015

    authors: Fuster O,Llop M,Dolz S,García P,Such E,Ibáñez M,Luna I,Gómez I,López M,Cervera J,Montesinos P,Moscardó F,Cordón L,Solves P,de Juan I,Palanca S,Bolufer P,Sanz MÁ,Barragán E

    更新日期:2013-12-01 00:00:00

  • Use of the receptor tyrosine kinase-like orphan receptor 1 (ROR1) as a diagnostic tool in chronic lymphocytic leukemia (CLL).

    abstract::Flow cytometry is commonly used to establish the diagnosis of chronic lymphocytic leukemia (CLL). A defined combination of antibodies discriminates between normal B cells and CLL cells (coexpression of CD5, CD19, and CD23). The receptor tyrosine-like orphan receptor one (ROR1) is an embryonic glycoprotein involved in ...

    journal_title:Leukemia research

    pub_type: 杂志文章

    doi:10.1016/j.leukres.2011.04.006

    authors: Uhrmacher S,Schmidt C,Erdfelder F,Poll-Wolbeck SJ,Gehrke I,Hallek M,Kreuzer KA

    更新日期:2011-10-01 00:00:00

  • SOX11 as a minimal residual disease marker for Mantle cell lymphoma.

    abstract::Recent studies have identified SOX11 as a novel diagnostic marker for mantle cell lymphoma (MCL). We quantified SOX11 by a truly mRNA specific qPCR assay in longitudinal peripheral blood samples from 20 patients and evidenced a close relationship of SOX11 expression and clinical status of the patients. In eight patien...

    journal_title:Leukemia research

    pub_type: 杂志文章

    doi:10.1016/j.leukres.2014.04.007

    authors: Simonsen AT,Sørensen CD,Ebbesen LH,Bødker JS,Bentzen HH,Nyvold CG

    更新日期:2014-08-01 00:00:00

  • Considerations and challenges for patients with refractory and relapsed acute myeloid leukaemia.

    abstract::Despite advances in understanding the complexities of acute myeloid leukaemia (AML), the treatment of refractory or relapsed AML (rrAML) remains a daunting clinical challenge. Numerous clinical trials have failed to identify new treatments or combinations of existing therapies that substantially improve outcomes and s...

    journal_title:Leukemia research

    pub_type: 杂志文章,评审

    doi:10.1016/j.leukres.2016.05.025

    authors: Kell J

    更新日期:2016-08-01 00:00:00

  • In-vitro effects of antineoplastic prostaglandins on human leukemic cell growth and normal myelopoiesis.

    abstract::The effects of prostaglandin (PG)E1, PGD2 and 9-deoxy-delta 9-PGD2 (PGJ2) on the clonogenic growth of six kinds of human leukemic cell lines (K562, KG1, HL60, U937, THP1 and Molt4) and normal human myeloid progenitor cells (CFU-GM) were studied using semisolid agar cultures. While the degree of suppression of leukemic...

    journal_title:Leukemia research

    pub_type: 杂志文章

    doi:10.1016/0145-2126(86)90087-1

    authors: Tsao CJ,Ozawa K,Hosoi T,Urabe A,Takaku F

    更新日期:1986-01-01 00:00:00

  • Cytotoxic effects of celecoxib on Raji lymphoma cells correlate with aggravated endoplasmic reticulum stress but not with inhibition of cyclooxygenase-2.

    abstract::Inhibition of cyclooxygenase 2 (COX-2) by the selective COX-2 inhibitor celecoxib has been suggested as potentially useful for B-cell lymphoma therapy. However, additional pharmacological activities of celecoxib have been discovered and have challenged the notion that its antitumor effects are mediated primarily via t...

    journal_title:Leukemia research

    pub_type: 杂志文章

    doi:10.1016/j.leukres.2009.09.028

    authors: Chen ST,Thomas S,Gaffney KJ,Louie SG,Petasis NA,Schönthal AH

    更新日期:2010-02-01 00:00:00

  • HL-R5 and HL-D4: two differentiation resistant HL-60 variants.

    abstract::A wide range of different agents are capable of inducing the onset of HL-60 differentiation along the myeloid lineage. The diversity of these agents has made the analysis of the molecular mechanisms involved in the regulation of the onset and progress of terminal differentiation in these cells difficult. We have adapt...

    journal_title:Leukemia research

    pub_type: 杂志文章

    doi:10.1016/0145-2126(89)90081-7

    authors: Darling DC,Linskens MH,Farzaneh F

    更新日期:1989-01-01 00:00:00

  • Aven overexpression: association with poor prognosis in childhood acute lymphoblastic leukemia.

    abstract::Aven expression has recently been identified as an anti-apoptotic protein. In this study, Aven expression in 91 children with acute lymphoblastic leukemia (ALL) was investigated for possible correlation with clinical features at diagnosis and treatment outcome. Aven expression was found to be higher in patients >or=10...

    journal_title:Leukemia research

    pub_type: 杂志文章

    doi:10.1016/j.leukres.2005.11.001

    authors: Choi J,Hwang YK,Sung KW,Kim DH,Yoo KH,Jung HL,Koo HH

    更新日期:2006-08-01 00:00:00

  • Variations in incidence of childhood leukaemia in South East Scotland (1970-1984).

    abstract::Concern has been expressed recently about apparent increases in the incidence of leukaemia amongst young people living in certain geographical areas. We analysed the incidence of childhood leukaemia in South-East Scotland (excluding North-East Fife) from 1970 to 1984. There was a significant geographical variation in ...

    journal_title:Leukemia research

    pub_type: 杂志文章

    doi:10.1016/0145-2126(86)90091-3

    authors: Gerrard M,Eden OB,Stiller CA

    更新日期:1986-01-01 00:00:00

  • Using haplotype analysis to elucidate significant associations between genes and Hodgkin lymphoma.

    abstract::In this study, we estimated the association between the inferred haplotypes in the inflammation, DNA repair, and folate pathways, and developed risk models for Hodgkin lymphoma. The study population consisted of 200 Hodgkin lymphoma cases and 220 controls. A susceptible association was observed on the XPC gene with ha...

    journal_title:Leukemia research

    pub_type: 杂志文章

    doi:10.1016/j.leukres.2012.07.014

    authors: D'Amelio AM Jr,Monroy C,El-Zein R,Etzel CJ

    更新日期:2012-11-01 00:00:00

  • Combination therapy with arsenic trioxide, all-trans retinoic acid, and chemotherapy in acute promyelocytic leukemia patients with various relapse risks.

    abstract::To improve the recovery rate of high-risk patients with acute promyelocytic leukemia (APL), we used all-trans retinoic acid (ATRA)/arsenic trioxide (ATO)/daunorubicin combination in remission induction, daunorubicin and cytarabine in consolidation, and ATRA/ATO/methotrexate ± 6-mercaptopurine in maintenance treatment ...

    journal_title:Leukemia research

    pub_type: 杂志文章

    doi:10.1016/j.leukres.2012.03.027

    authors: Huang H,Qin Y,Xu R,You X,Teng R,Yang L,Xu M,Liu H

    更新日期:2012-07-01 00:00:00

  • Combined treatment of 3-hydroxyflavone and imatinib mesylate increases apoptotic cell death of imatinib mesylate-resistant leukemia cells.

    abstract::Imatinib mesylate, a Bcr/Abl tyrosine kinase inhibitor, is widely used in treating chronic myeloid leukemia. However, drug-resistance of leukemia cells becomes an emergent problem. Herein, various flavonoids were screened for applicability in leukemia treatment, and 3-hydroxyflavone (3-HF) was found to be most effecti...

    journal_title:Leukemia research

    pub_type: 杂志文章

    doi:10.1016/j.leukres.2012.05.018

    authors: Kim JH,Song M,Kang GH,Lee ER,Choi HY,Lee C,Kim JH,Kim Y,Koo BN,Cho SG

    更新日期:2012-09-01 00:00:00

  • Relation between platinum-DNA adducts and complete remission in adult acute nonlymphocytic leukemia.

    abstract::The purpose of this study was to determine the relationship between platinum-DNA adducts in leukemic cells and the success of remission induction therapy in adult patients with acute nonlymphocytic leukemia (ANLL). Freshly isolated cells from pre-treatment bone marrow aspirates of 14 patients were incubated with cispl...

    journal_title:Leukemia research

    pub_type: 临床试验,杂志文章

    doi:10.1016/0145-2126(94)90064-7

    authors: Armstrong SG,Browman GP,Benger AM,Meyer RM,McKay KL,Singh G

    更新日期:1994-09-01 00:00:00

  • Sensitive and quantitative detection of mutations associated with clinical resistance to STI-571.

    abstract::Resistance to chronic myeloid leukemia (CML) drug STI571 has been associated with point mutations in the kinase domain of BCR-ABL. For example, the mutation T315I (g. 68721C>T) and, to a lesser extent, Y253F (g. 58796A>T) appear in a significant proportion of patients resistant to treatment. Mutations appear intimatel...

    journal_title:Leukemia research

    pub_type: 杂志文章

    doi:10.1016/s0145-2126(03)00066-3

    authors: Liu WH,Makrigiorgos GM

    更新日期:2003-11-01 00:00:00

  • Malignant hematopoietic cell lines: in vitro models for the study of mantle cell lymphoma.

    abstract::Mantle cell lymphoma (MCL) is a distinct type of B cell malignancy and accounts for approximately 5-10% of non-Hodgkin's lymphomas (NHL). The characteristic cytogenetic aberration in MCL is the translocation (11;14)(q13;q32) present in virtually all cases. This rearrangement at the BCL1 locus at 11q13 dysregulates the...

    journal_title:Leukemia research

    pub_type: 杂志文章

    doi:10.1016/s0145-2126(02)00026-7

    authors: Drexler HG,MacLeod RA

    更新日期:2002-09-01 00:00:00

  • Infectious feline leukaemia virus is erythrosuppressive in vitro.

    abstract::The direct effect of the feline leukaemia virus (FeLV) on erythroid colony formation in vitro was investigated. Bone marrow mononuclear cells (BMMC) from FeLV-naïve, specific-pathogen-free (SPF), adult cats were inoculated with FeLVs of characterized strains and biologically cloned subgroups and the subsequent develop...

    journal_title:Leukemia research

    pub_type: 杂志文章

    doi:10.1016/0145-2126(86)90237-7

    authors: Rojko JL,Cheney CM,Gasper PW,Hamilton KL,Hoover EA,Mathes LE,Kociba GJ

    更新日期:1986-01-01 00:00:00

  • The discovery of endothelial progenitor cells. An historical review.

    abstract::Although the earliest sites of hematopoietic cell and endothelial cell differentiation in the yolk sac blood islands were identified about 100 years ago, cells with hemangioblast properties have not yet been identified in vivo. Endothelial cells differentiate from angioblasts in the embryo and from endothelial progeni...

    journal_title:Leukemia research

    pub_type: 历史文章,杂志文章,评审

    doi:10.1016/j.leukres.2006.10.014

    authors: Ribatti D

    更新日期:2007-04-01 00:00:00

  • Establishment and characterization of a human EBV-negative B cell line (MN 60).

    abstract::A permanent cell line, MN 60, was established from the peripheral blood of a patient with an acute lymphoblastic leukemia (ALL) classified morphologically as being of the L3 type. Cell growth started rapidly in vitro and no feeder cells were needed. Cells of the MN-60 line were identical to the original leukemic cells...

    journal_title:Leukemia research

    pub_type: 杂志文章

    doi:10.1016/0145-2126(82)90085-6

    authors: Roos G,Adams A,Giovanella B,Lundgren E,Nilsson K,Nordenson I,Sundström C

    更新日期:1982-01-01 00:00:00

  • Serum double monoclonal components and hematological malignancies: only a casual association? Review of 34 cases.

    abstract::A double monoclonal component (MC) detected in the serum and/or urine represents a very rare occurrence (2-6% of monoclonal gammopathies). In this study, we report 34 patients with double serum MCs, focusing on the associated diseases. The diagnosis was made using high-resolution serum protein electrophoresis and immu...

    journal_title:Leukemia research

    pub_type: 杂志文章

    doi:10.1016/j.leukres.2012.05.008

    authors: Guastafierro S,Ferrara MG,Sica A,Parascandola RR,Santangelo S,Falcone U

    更新日期:2012-10-01 00:00:00